PuSH - Publikationsserver des Helmholtz Zentrums München

Dorgham, K.* ; Neumann, A.U. ; Decavele, M.* ; Luyt, C.E.* ; Yssel, H.* ; Gorochov, G.*

Considering personalized Interferon-β therapy for COVID-19.

Antimicrob. Agents Chemother. 65:e00065-21 (2021)
DOI Verlagsversion bestellen
: Verlagsversion online verfügbar 10/2021
Davoudi-Monfared et al. (1) report in this Journal the results from a clinical trial on COVID-19 patients showing that subcutaneous administration of interferon-β (IFN-β) was associated with a more rapid recovery from SARS-CoV-2 infection and decreased mortality.….
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Letter to the Editor
Schlagwörter Biotherapy ; Covid-19 ; Interferon Beta
ISSN (print) / ISBN 0066-4804
e-ISSN 1098-6596
Quellenangaben Band: 65, Heft: 4, Seiten: , Artikelnummer: e00065-21 Supplement: ,
Verlag American Society for Microbiology (ASM)
Verlagsort 1752 N St Nw, Washington, Dc 20036-2904 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Environmental Medicine (IEM)